Detalles de la búsqueda
1.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 99(7): 1290-1299, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654658
2.
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry.
Cytotherapy
; 23(6): 483-487, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33678598
3.
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Cancer
; 126(5): 1004-1015, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31774557
4.
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 105(6): 1507-1516, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241850
5.
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 105(1): 47-58, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537691
6.
CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT).
Am J Hematol
; 95(8): 892-899, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303111
7.
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia.
Cancer
; 125(20): 3566-3573, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31225904
8.
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
Br J Haematol
; 184(5): 782-787, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467839
9.
Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Ann Hematol
; 98(10): 2389-2398, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392462
10.
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Biol Blood Marrow Transplant
; 24(7): 1406-1414, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29678639
11.
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT.
Am J Hematol
; 93(7): 859-866, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29644709
12.
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
Am J Hematol
; 93(12): 1532-1542, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218444
13.
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Cancer
; 123(5): 824-831, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27906458
14.
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 102(11): 1810-1822, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28883081
15.
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 102(2): 224-234, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27927772
16.
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission.
Am J Hematol
; 92(12): 1318-1323, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28960419
17.
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
Am J Hematol
; 92(8): 789-796, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439910
18.
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 122(19): 2941-51, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27309127
19.
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 122(12): 1880-7, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018549
20.
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 101(6): 773-80, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26969081